<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35490774</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1872-7549</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>429</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>28</Day>
            </PubDate>
          </JournalIssue>
          <Title>Behavioural brain research</Title>
          <ISOAbbreviation>Behav Brain Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Myricitrin exhibits antidepressant-like effects and reduces IL-6 hippocampal levels in the chronic mild stress model.</ArticleTitle>
        <Pagination>
          <StartPage>113905</StartPage>
          <MedlinePgn>113905</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbr.2022.113905</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0166-4328(22)00173-5</ELocationID>
        <Abstract>
          <AbstractText>The flavonoid myricitrin showed an antidepressant-like effect in the tail suspension test and increased hippocampal neurogenesis, as well as demonstrating anti-inflammatory effects. Interestingly, inflammation has been linked to depression, and anti-inflammatory drugs showed promising results as antidepressant-like drugs. Thus, the present study evaluated the effects of myricitrin in the chronic mild stress (CMS) model, a translational and valid animal model of depression, using the mini-experiment design to improve the reproducibility of the findings. The sucrose preference test (SPT), forced swim test (FST), and tail suspension test (TST) were the readouts of depressive-like phenotypes induced by CMS. Relative adrenal weight was employed as an index of the hypothalamus-pituitary-adrenal (HPA) axis activation. Interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha levels were measured in the hippocampus. Myricitrin (10 mg/kg, intraperitoneally, for 14 days) reversed depressive-like behaviors induced by CMS (increased immobility in the FST, the TST and anhedonia), as well as decreased adrenal hypertrophy and hippocampal levels of IL-6 in stressed mice. Similar results were observed by imipramine (20 mg/kg, intraperitoneally, for 14 days), a serotonin and norepinephrine reuptake inhibitor (positive control). A significant correlation was observed between immobility time in the TST, and hippocampal IL-6 levels. Hippocampal TNF-α levels were not affected by CMS or drug treatment. In conclusion, myricitrin exhibited an antidepressant-like profile in CMS, and this effect may be associated with its anti-inflammatory activity.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pereira</LastName>
            <ForeName>Marcela</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Paraná, Pharmacology Department, Curitiba, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Siba</LastName>
            <ForeName>Isadora P</ForeName>
            <Initials>IP</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Paraná, Pharmacology Department, Curitiba, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Acco</LastName>
            <ForeName>Alexandra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Paraná, Pharmacology Department, Curitiba, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Correia</LastName>
            <ForeName>Diego</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Paraná, Pharmacology Department, Curitiba, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lapa</LastName>
            <ForeName>Fernanda R</ForeName>
            <Initials>FR</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Santa Catarina, Laboratory of Neurobiology of Pain and Inflammation, Physiological Sciences Department, Santa Catarina, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Santos</LastName>
            <ForeName>Adair R S</ForeName>
            <Initials>ARS</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Santa Catarina, Laboratory of Neurobiology of Pain and Inflammation, Physiological Sciences Department, Santa Catarina, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ruani</LastName>
            <ForeName>Ana P</ForeName>
            <Initials>AP</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Santa Catarina, Chemistry Department, Santa Catarina, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pizzolatti</LastName>
            <ForeName>Moacir G</ForeName>
            <Initials>MG</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Santa Catarina, Chemistry Department, Santa Catarina, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andreatini</LastName>
            <ForeName>Roberto</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Federal University of Paraná, Pharmacology Department, Curitiba, Brazil. Electronic address: randreatini@ufpr.br.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Behav Brain Res</MedlineTA>
        <NlmUniqueID>8004872</NlmUniqueID>
        <ISSNLinking>0166-4328</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Anhedonia</Keyword>
        <Keyword MajorTopicYN="N">Antidepressant</Keyword>
        <Keyword MajorTopicYN="N">Cytokines</Keyword>
        <Keyword MajorTopicYN="N">Forced swim</Keyword>
        <Keyword MajorTopicYN="N">Mice</Keyword>
        <Keyword MajorTopicYN="N">Tail suspension</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>1</Day>
          <Hour>19</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35490774</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bbr.2022.113905</ArticleId>
        <ArticleId IdType="pii">S0166-4328(22)00173-5</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
